Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Polyguluronic acid" patented technology

Sulfated Polyguluronic Acid Ester and its preparation method and uses

A polyguluronic acid ester having a chemical name of L-polyguluronic aldonic acid-2, 3-sulfuric acid, is prepared through the steps of first obtaining L-polyguluronic aldonic acid through acid degradation and pH grading of alginic acid, proceeding secondary acid degradation and pH grading, carrying out ultrafiltration, deposition, dewatering and drying, using sulfating agent to subject the polyguluronic acid ester to sulfation, alcohol deposition, scouring, alkaline treatment, filtering, drying and disintegrating. The polyguluronic acid ester according to the invention has strong negative ion concentration property, it can be utilized in the preparation of medicament for treating or preventing urinary lithiasis.
Owner:MARINE BIOMEDICAL RES INST OF QINGDAO CO LTD

Novel alginate lyase, preparation method and application thereof

The invention discloses an alginate lyase (Alg509) derived from marine bacteria and a gene thereof, and also disclosed a method for recombinant expression and preparation of the alginate lyase. According to the method, the alg509 gene is cloned into an E. coli expression vector, and the vector is transformed into an E. coli host strain to obtain a recombinant engineering strain which can heterologously express the enzyme. The alginate lyase Alg509 disclosed in the invention has high enzyme activity, the specific enzyme activity can reach up to 48000 U / mg and above, the optimum reaction pH is 10, the optimum reaction temperature is 55 DEG C, and the enzyme activity has no dependence on various metal ions. The enzyme is active to sodium alginate, poly-guluronic acid (polyG) and ploymannuronic acid (polyM), and can completely degrade sodium alginate to produce alginate oligomers such as alginate disaccharide, alginate trisaccharide, alginate tetrasccharide, etc. The enzyme exhibits strongbasophilia, has certain tolerance to high pH, has certain potential of industrial applications, and can be widely applied in the fields of agriculture, food, feed additive, medicine and the like.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Method for preparing alginate oligosaccharide monomers by using microwave radiation

The invention provides a method for preparing alginate oligosaccharide monomers by using microwave radiation. The method comprises the following steps of: preparing polymannuronic acid or polyguluronic acid in algin, subjected to graded purification, into solutions or suspensions with different concentrations; performing microwave radiation in a microwave reaction system for degradation for 5 to 30 minutes; then cooling, filtering and freeze-drying the degradation product to obtain an oligosaccharide mixture; and separating and purifying the oligosaccharide mixture by using a gel column chromatography to obtain oligosaccharide monomers with different polymerization degrees. The method has the advantages that the degradation efficiency is high, the yield of oligosaccharide is high, acid or a buffer salt is not added during the degradation, few byproducts are generated, the after-treatment is simple and convenient, the product is easy to separate and purify, clean and environment-friendly effects are achieved, the cost is low, oligosaccharide mixtures with different molecular weight distributions and oligosaccharide monomers with different polymerization degrees can be prepared according to different aims and purposes, and the product is applied to various fields of foods, medicaments, chemical industry and the like.
Owner:OCEAN UNIV OF CHINA

Application of guluronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury

The invention provides application of guluronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury. Guluronic acid oligomers with different molecular weights, which are obtained by degrading polyguluronic acid graded and purified from algin, can lower the hepatosomatic index increase caused by alcoholic injury, resist triglyceride and cholesterol increase caused by alcohol, effectively lower glutamic-pyruvic transaminase and glutamic oxaloacetic transaminase increase in serum caused by alcohol, enhance the total oxidation resistance, glutathione level and superoxide dismutase activity in the serum, inhibit the generation of malonaldehyde in the liver caused by alcohol, lower the mouse drunkenness rate, prolong the mouse drunkenness time, and shorten the sober-up time, thereby implementing the protective action and hangover alleviating function on alcoholic hepatic injury. The products provided by the invention are derived from marine natural products, have the advantages of abundant resources, high industrialization tendency, high safety, high effectiveness and the like, and have wide development and application prospects in the aspects of prevention and treatment of alcoholic hepatic injury, hangover alleviation and liver protection.
Owner:OCEAN UNIV OF CHINA

Sodium alginate containing high molecular weight polyguluronic acid and application thereof

The invention relates to the field of sodium alginate, in particular to sodium alginate containing high molecular weight (HMW) a-1, 4-L-polyguluronic acid, and an application thereof in immobilized cells and microorganisms. Stems and leaves of ripe kelp are taken as raw materials, the raw materials are crushed and then subjected to organic solvent degreasing and hot water extraction, and residues are collected; the residues are subjected to thermokalite extraction and then filtered, supernatant fluid is collected and subjected to hydrochloric acid precipitation, neutralization, dehydration and drying to obtain the sodium alginate containing HMW high polyguluronic acid content, in which the content of polyguluronic acid is larger than or equal to 90 mol%, and the molecular weight is larger than or equal to 70 kD. The sodium alginate has the advantages of rich raw material sources, good safety, unique structure, large molecular weight, high gel strength and simple preparation technology. A manufactured microcapsule is 0.5 mm-5.0 mm in particle size, so that large-scale preparation and product reclamation are facilitated; and the microcapsule is manufactured under physiological conditions, so that physiological activities of cells and microorganisms are guaranteed.
Owner:青岛聚大洋藻业集团有限公司

Conjugate of polymer and biological stain and preparation method and application thereof

The invention provides a conjugate of a polymer and a biological stain and a preparation method and application of the conjugate. The conjugate has the formula G-X-B, wherein the polymer G is selected from the group consisting of glucans, fructosans, polymannuronic acid, polyguluronic acid, heteropolysaccharides, mono- or hetero-polysaccharides, mono- or hetero-polyuronic acid polysaccharides, mono- or hetero-polyuronic acid sulfate esters, hydrophilic alcohol high polymers, polylysine, polyglutamic acid and polyaspartic acid; the linking group X is a C1-C10 organic group; and the biological stain or a derivative B thereof may be toluidine blue, methylene blue, Evans blue, neutral red, Janus green or bright cresol purple. The conjugate can stain bilateral neck and submaxillary or submental lymphatic vessels and lymph nodes in New Zealand white rabbits by indirect lymph staining method, without diffusion in tongue body. No obvious toxic and adverse effects appear in all experimental animals in each group, and no obvious pathological changes appear in histological examination of internal organs.
Owner:OCEAN UNIV OF CHINA

Incision difunctional alginate lyase Aly2 generating various monosaccharide products, encoding gene of Aly2 and application of Aly2

The invention relates to incision difunctional alginate lyase Aly2 generating various monosaccharide products, an encoding gene of the Aly2 and an application of the Aly2. The amino acid sequence of the Aly2 is as shown in SEQ ID NO. 2, and the nucleotide sequence of the encoded Aly2 is as shown in SEQ ID NO. 1. The specific activity of prepared gene engineering recombinant protein rAly2 for alginate, polyguluronic acid and polymannuronic acid is 2025U / mg, 3672U / mg and 1324U / mg, so that the gene engineering recombinant protein rAly2 is a difunctional enzyme. The enzyme is an incision enzyme, and final main products are unsaturated disaccharide and unsaturated trisaccharide when an alginate polysaccharide substrate is thoroughly degraded. When different oligosaccharide substrates are degraded, various monosaccharide products such as saturated M and G or unsaturated delta can be generated. Besides, the rAly2 is stable in biochemical property, is a potential tool enzyme, can be applied tothe field of medicines, food and the like and has a wide application prospect.
Owner:SHANDONG UNIV

Sulfated Polyguluronic Acid Ester and its preparation method and uses

A polyguluronic acid ester having a chemical name of L-polyguluronic aldonic acid-2, 3-sulfuric acid, is prepared through the steps of first obtaining L-polyguluronic aldonic acid through acid degradation and pH grading of alginic acid, proceeding secondary acid degradation and pH grading, carrying out ultrafiltration, deposition, dewatering and drying, using sulfating agent to subject the polyguluronic acid ester to sulfation, alcohol deposition, scouring, alkaline treatment, filtering, drying and disintegrating. The polyguluronic acid ester according to the invention has strong negative ion concentration property, it can be utilized in the preparation of medicament for treating or preventing urinary lithiasis.
Owner:MARINE BIOMEDICAL RES INST OF QINGDAO CO LTD

Process for treating alginic acid to produce polyguluronic acids or concentrated solutions for use in producing polyguluronic acids

InactiveUS6586589B1Sugar derivativesInksPeriodate saltFree iodine
A method of treating alginic acid to produce polyguluronic acids. The method involves: (a) mixing the alginic acid with water and lithium hydroxide in respective amounts sufficient to form a reaction mixture that is an acidic solution comprising at least 5 wt % of the alginic acid; (b) treating the reaction mixture, with addition of a periodic acid or a periodate salt, to effect an oxidation of the alginic acid that results in formation of (i) an oxidized product that, upon acidifying and heating, hydrolyzes into a plurality of components including polyguluronic acids that are substantially free of mannuronic acid contamination, with the polyguluronic acids having an average degree of polymerization of less than 20; and (ii) free iodine; (c) separating the free iodine from the reaction mixture; (d) acidifying and heating the reaction mixture to hydrolyze the oxidized product into the plurality of components; (e) adjusting the pH of the reaction mixture to form a precipitate of the polyguluronic acids; and (f) recovering the precipitate. There is also disclosed a method of treating alginic acid using steps (a), (b) and (c) to form concentrated solutions for use in producing polyguluronic acids.
Owner:SEIKO EPSON CORP

Alginate lyase SHA-3 gene and prokaryotic expression vector thereof

The invention discloses an alginate lyase SHA-3 gene with a nucleotide sequence as shown in SEQ ID NO:1. The invention establishes a prokaryotic expression vector of the alginate lyase SHA-3 gene. The vector can obtain an expression product, namely alginate lyase SHA-3 within relatively-short time, has wide substrate specificity, can take polymannuronic acid PolyM or polyguluronic acid PolyG as a substrate, and has the enzyme activity of 12U / mg so as to be a difunctional enzyme with a wide application prospect. The prokaryotic expression vector and a whole expression system are easily operated and are conveniently used for realizing industrial production.
Owner:KUNMING UNIV OF SCI & TECH

Preparation method of nano microspheres with biological activity

The invention relates to the field of nano gel materials, in particular to a preparation method of nano microspheres with biological activity. The method comprises the following steps: dissolving sodium alginate and polyguluronic acid in a solvent, adding an activator for activation to obtain an activation solution, mixing the activation solution with a calcium salt solution, adding aminomercaptan, and carrying out self-crosslinking in an oxygen-containing atmosphere to obtain the nano microspheres with biological activity. The preparation method is simple and efficient; the nano microspherescan be directly prepared by a one-step method; the prepared nano microsphere has good drug loading property and targeted drug delivery property; under the matching effect of polyguluronic acid, the nano microspheres have the capability of stimulating the immune response of organisms.
Owner:ZHEJIANG OCEAN UNIV

Process for the manufacture of polyguluronic acids

It is the object of the present invention to provide an industrially useful process for the manufacture of polyguluronic acids having degrees of polymerization less than 20 and substantially free of mannuronic acid contamination. Alginate salts of organic bases are quite soluble in aqueous solution, and remain soluble in aqueous solution throughout a hydrolysis reaction in the range of pH values at which the acidic hydrolysis is effected at a reasonably fast rate. Based on this finding, a solution containing 5 wt. % or more of alginic acid prepared by dissolving alginic acid in water by neutralization with an organic base is provided and then hydrolyzed under acidic conditions, followed by selective precipitation of polyguluronic acids under acidic conditions.
Owner:SEIKO EPSON CORP

Alginic acid lyase SHA-5 gene and prokaryotic expression vector thereof

The invention discloses an alginic acid lyase SHA-5 gene. The nucleotide sequence of the alginic acid lyase SHA-5 gene is shown as SEQ ID NO:1. A prokaryotic expression vector of the alginic acid lyase SHA-5 gene is structured, the expression product alginic acid lyase SHA-5 can be obtained in a short time through the vector, and the vector has wide substrate specificity; both polymannuronic acid PolyM and polyguluronic acid PolyG can be used as a substrate, the enzyme activity reaches 17 U / mg, and the alginic acid lyase SHA-5 is difunctional and has wide application prospects. The prokaryotic expression vector and an integral expression system are easy to operate, and industrial production is convenient.
Owner:KUNMING UNIV OF SCI & TECH

Endo-alginate lyase and coding gene and application thereof

The invention discloses endo-alginate lyase and a coding gene and application thereof. A primer is designed and synthesized by taking genome DNA of a Vibriosp.MCCC 1A13243 as a template, an endo-alginate lyase gene is amplified through PCR, the gene is cloned into a pET-22b expression vector, induced expression is carried out in escherichia coli E.coli BL21, and affinity chromatography purification is carried out by adopting Ni-Sepharose to obtain the recombinant endo-alginate lyase protein with higher purity. The optimum temperature of the enzyme is 35 DEG C, the optimum pH of the enzyme is 8.5, and the enzyme has good stability in the ranges of 0-65 DEG C and pH 4.5-10.5; co<2+>, Cu<2+>, Mn<2+> and Fe<3+> can obviously promote the enzyme activity; and the enzyme has the highest degradation effect on sodium alginate and can further degrade polyguluronic acid and polymannuronic acid, and a main product for degrading the three substrates is disaccharide. The endo-alginate lyase has advantages in the aspect of producing alginate oligosaccharide, especially brown algae disaccharide.
Owner:THIRD INST OF OCEANOGRAPHY MINIST OF NATURAL RESOURCES

Novel alginate lyase BY17PV7 and application thereof

The invention relates to novel alginate lyase BY17PV7 and application thereof. The alginate lyase BY17PV7 is derived from Microbulbifer sp.BY17, the amino acid sequence of the alginate lyase BY17PV7 is shown as SEQ ID NO.1, and the nucleotide sequence of the coding gene by17pv7 is shown as SEQ ID NO. 2. The enzyme activity of the recombinant alginate lyase BY17PV7 can reach 124.7 U / mg, the optimum reaction temperature is 43 DEG C, the optimum reaction pH is 8.9, the alginate lyase BY17PV7 is kept relatively stable under the conditions of 20-40 DEG C and pH of 7.0-8.9, the alginate lyase BY17PV7 has degradation activity on sodium alginate, polymannuronic acid and polyguluronic acid, alginate oligosaccharides generated by enzymolysis are trisaccharide and tetrasaccharide, and the alginate lyase BY17PV7 has antioxidant activity. The alginate lyase BY17PV7 can be applied to the fields of alginate oligosaccharide production and industry, food, medicine and the like.
Owner:FUZHOU UNIV

Synbiotic preparation

The invention provides a synbiotic preparation. The synbiotic preparation is a microsphere preparation prepared from polyguluronic acid and probiotics. The synbiotic preparation adopts the polyguluronic acid as a carrier material, the polyguluronic acid has an anti-digestion characteristic and can promote growth of the probiotics, and as a carrier of active probiotics, the polyguluronic acid can protect the probiotics from digestion of gastric acid and digestive enzyme in the alimentary tracts, so the viable count of the probiotics arriving the intestinal tracts is increased; and an embeddingmaterial used can promote growth of the probiotics and has double effects of protecting the activity of the probiotics and promoting proliferation of the probiotics in the intestinal tracts.
Owner:DALIAN OCEAN UNIV

Recombinant alginate lyase AlyL7 and application thereof

PendingCN114231514AHigh specific vitalityOvercome the shortcomings of low catalytic efficiencyFermentationVector-based foreign material introductionPolymannuronic acidNucleotide
The invention relates to a recombinant alginate lyase AlyL7 and application thereof. The amino acid sequence of the alginate lyase is shown as SEQ ID NO.1, and the nucleotide sequence of a coding gene of the alginate lyase is shown as SEQ ID NO.2. The recombinant alginate lyase belongs to bifunctional alginate lyase, the optimum reaction temperature of the recombinant alginate lyase is 40 DEG C, the optimum reaction pH of the recombinant alginate lyase is 9.0, the recombinant alginate lyase is stable under the conditions that the temperature is 0-25 DEG C and the pH is 5.0-10.0, and the recombinant alginate lyase has degradation activity on sodium alginate, polyguluronic acid and polymannuronic acid. The recombinant alginate lyase also belongs to an incision enzyme, and a final product obtained by enzymolysis of sodium alginate by the recombinant alginate lyase comprises unsaturated 1-5 sugars and mainly comprises unsaturated 2-3 sugars. The alginate lyase is high in reaction speed and high in efficiency, and has good industrial application potential.
Owner:FUZHOU UNIV

Application of polyguluronic acid sulfate in the preparation of anti-hepatitis B virus medicine

The invention provides application of polyguluronate sulfate to anti-hepatitis B virus medicine preparation. Experiments prove that the polyguluronate sulfate is capable of well inhibiting expression of an HBV (hepatitis B virus) HBsAg (hepatitis B surface antigen) and an HBV HBeAg (hepatitis Be antigen) in a hepatocellular carcinoma cell line HepG2.2.15, remarkably inhibiting expression of HBV-S mRNA (messenger ribonucleic acid) in the hepatocellular carcinoma cell line HepG2.2.15, enhancing generation and secretion of anti-virus immunity-associated IFN (interferon)-beta in cells and activating NF (nuclear factor)-kappa B and MAPK (mitogen-activated protein kinase) signal pathways. The polyguluronate sulfate which is a marine sulfated polysaccharide compound has the advantages of rich resources, low cost, high safety and the like, and is obviously superior to positive control drug lamivudine in anti-HBV effect, thereby being promising in application prospect of anti-hepatitis B virus medicine preparation.
Owner:MARINE BIOMEDICAL RES INST OF QINGDAO CO LTD +1

Application of oligomeric guluronic acid in the preparation of drugs, health products or dietary supplements for the prevention and treatment of alcoholic liver injury

The invention provides application of guluronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury. Guluronic acid oligomers with different molecular weights, which are obtained by degrading polyguluronic acid graded and purified from algin, can lower the hepatosomatic index increase caused by alcoholic injury, resist triglyceride and cholesterol increase caused by alcohol, effectively lower glutamic-pyruvic transaminase and glutamic oxaloacetic transaminase increase in serum caused by alcohol, enhance the total oxidation resistance, glutathione level and superoxide dismutase activity in the serum, inhibit the generation of malonaldehyde in the liver caused by alcohol, lower the mouse drunkenness rate, prolong the mouse drunkenness time, and shorten the sober-up time, thereby implementing the protective action and hangover alleviating function on alcoholic hepatic injury. The products provided by the invention are derived from marine natural products, have the advantages of abundant resources, high industrialization tendency, high safety, high effectiveness and the like, and have wide development and application prospects in the aspects of prevention and treatment of alcoholic hepatic injury, hangover alleviation and liver protection.
Owner:OCEAN UNIV OF CHINA

A kind of alginate lyase, its preparation method and application

The invention discloses a alginate lyase (Alg509) derived from marine bacteria and its gene. At the same time, the method for recombinant expression and preparation of the alginate lyase is also disclosed, which is about to alg509 The gene is cloned into an Escherichia coli expression vector, and the vector is transformed into an Escherichia coli host bacterium to obtain a recombinant engineering strain capable of heterologously expressing the enzyme. The alginate lyase Alg509 disclosed by the present invention has high enzyme activity, the specific enzyme activity can reach more than 48000U / mg, the optimum reaction pH is 10, the optimum reaction temperature is 55°C, and the enzyme activity has no dependence on various metal ions . The enzyme is active on sodium alginate, polyguluronic acid (polyG) and polymannuronic acid (polyM), and can completely degrade sodium alginate to produce fucobiose, fucoidanose, and fucoidan Sugar and other fucoidan oligosaccharides. The enzyme exhibits strong basophilicity, has a certain tolerance to high pH, ​​has a certain potential for industrial application, and can be widely used in agriculture, food, feed additives, medicine and other fields.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Application of polyguluronic acid propyl sulfate in preparation of anticoagulant medicine

The invention provides application of propyl polyguluronate sulfate in the preparation of anticoagulants. The molecular skeleton of the propyl polyguluronate sulfate is linear glycosidic polymer formed by connecting L-guluronic acid through alpha-(1,4) glucosidic bond having the following structural formula shown in the scpecification, wherein R is CH2CH (OH)CH3 or CH2CH (OSO3-)CH3 or metal cation, R ' is H or SO<3><->, n is not more than 100. As prove by experiments, that propyl polyguluronate sulfate can be use for the treatment of hypercoagulable diseases such as thrombosis, and has low bleeding risk, and is mainly characterized in that the blood coagulation time in mice is remarkably prolon, the aggregation of platelets is inhibited, and the activity of the fibrinolysis system is improved, but the bleeding time is not prolonged significantly. The propyl polyguluronate sulfate is used for the treatment of hypercoagulable diseases such as thrombus. A series of experiments prove thatthe propyl polyguluronate sulfate can be developed into an anticoagulant drug and has a broad development and application prospect.
Owner:MARINE BIOMEDICAL RES INST OF QINGDAO CO LTD

A kind of endo-algin lyase, its encoding gene and application

The invention discloses an endo-algin lyase, its encoding gene and application. The present invention takes the genomic DNA of Vibrio sp.MCCC 1A13243 as a template, designs and synthesizes primers, amplifies the endo-alginate lyase gene by PCR, and clones the gene into the pET-22b expression vector. Induced expression in BL21 and purified by Ni-Sepharose affinity chromatography to obtain a higher-purity recombinant endo-algin lyase protein. The optimum temperature of the enzyme is 35℃, the optimum pH is 8.5, and the stability is good in the range of 0~65℃ and pH 4.5~10.5; Co 2+ , Cu 2+ , Mn 2+ and Fe 3+ It can obviously promote the activity of the enzyme; the enzyme has the strongest degradation effect on sodium alginate, and can also degrade polyguluronic acid and polymannuronic acid, and the main product of degrading these three substrates is disaccharide. The enzyme has advantages in the production of fucoidan oligosaccharides, especially fucoidobiose.
Owner:THIRD INST OF OCEANOGRAPHY MINIST OF NATURAL RESOURCES

Method for preparing alginate oligosaccharide monomers by using microwave radiation

The invention provides a method for preparing alginate oligosaccharide monomers by using microwave radiation. The method comprises the following steps of: preparing polymannuronic acid or polyguluronic acid in algin, subjected to graded purification, into solutions or suspensions with different concentrations; performing microwave radiation in a microwave reaction system for degradation for 5 to 30 minutes; then cooling, filtering and freeze-drying the degradation product to obtain an oligosaccharide mixture; and separating and purifying the oligosaccharide mixture by using a gel column chromatography to obtain oligosaccharide monomers with different polymerization degrees. The method has the advantages that the degradation efficiency is high, the yield of oligosaccharide is high, acid or a buffer salt is not added during the degradation, few byproducts are generated, the after-treatment is simple and convenient, the product is easy to separate and purify, clean and environment-friendly effects are achieved, the cost is low, oligosaccharide mixtures with different molecular weight distributions and oligosaccharide monomers with different polymerization degrees can be prepared according to different aims and purposes, and the product is applied to various fields of foods, medicaments, chemical industry and the like.
Owner:OCEAN UNIV OF CHINA

Preparation method of high-purity polyguluronic acid

InactiveCN112646054AConversion ensuredIncrease profitFermentationSodium bicarbonateUronic acid
The invention relates to the technical field of polyguluronic acid, in particular to high-purity polyguluronic acid which comprises the following raw materials in parts by weight: 40-55 parts of raw materials, and 16-34 parts of auxiliaries, more specificcally, 46 parts of raw materials and 28 parts of auxiliaries, and the raw materials include: 28-50 parts of algin, 10-25 parts of concentrated hydrochloric acid and 6-18 parts of sodium bicarbonate. The invention further discloses a preparation method of the high-purity polyguluronic acid, mannuronic acid can be converted into guluronic acid through isomerase, the guluronic acid is converted into guluronic acid of a single structure to be completely utilized, the product utilization rate and purity are high, it is guaranteed that the mannuronic acid is completely converted into the guluronic acid, the problem that the purity is not high in the later polymerization process is solved, the polymerization degree of polyguluronic acid purified through anion chromatography is low, operation is complex, and polyguluronic acid with the high polymerization degree can be obtained through a vacuum hot melt polycondensation method.
Owner:青岛海之林生物科技开发有限公司

A kind of alginate lyase sha-2 gene and its expression vector

The invention discloses an alginate lyase SHA‑2 gene, the nucleotide sequence of which is shown in SEQ ID NO: 1; the invention constructs a prokaryotic expression vector of the alginate lyase gene SHA‑2, the prokaryotic expression vector The expression product alginate lyase SHA‑2 can be obtained in a short period of time, and it has a wide range of substrate specificity, and can utilize both polymannuronate (Poly‑mannuronate, PolyM) and polyguluronic acid (Poly-guluronate, PolyG) is the substrate, and the enzyme activity reaches 5.2U / mg. It is a bifunctional enzyme with wide application prospects. The prokaryotic expression vector and the overall expression system of the present invention are easy to operate and convenient for industrial production.
Owner:KUNMING UNIV OF SCI & TECH

A kind of alginate lyase sha-5 gene and its prokaryotic expression vector

The invention discloses an alginic acid lyase SHA-5 gene. The nucleotide sequence of the alginic acid lyase SHA-5 gene is shown as SEQ ID NO:1. A prokaryotic expression vector of the alginic acid lyase SHA-5 gene is structured, the expression product alginic acid lyase SHA-5 can be obtained in a short time through the vector, and the vector has wide substrate specificity; both polymannuronic acid PolyM and polyguluronic acid PolyG can be used as a substrate, the enzyme activity reaches 17 U / mg, and the alginic acid lyase SHA-5 is difunctional and has wide application prospects. The prokaryotic expression vector and an integral expression system are easy to operate, and industrial production is convenient.
Owner:KUNMING UNIV OF SCI & TECH

An endo-type bifunctional alginate lyase aly2 producing multiple monosaccharide products, its encoding gene and application

The invention relates to an endo-type bifunctional alginate lyase Aly2 producing multiple monosaccharide products, its coding gene and application. The amino acid sequence of Aly2 is shown in SEQ ID NO.2, and the nucleotide sequence encoding Aly2 is shown in SEQ ID NO.1. The specific activities of the genetically engineered recombinant protein rAly2 prepared by the invention to alginate, polyguluronic acid and polymannuronic acid are 2025U / mg, 3672U / mg and 1324U / mg respectively, so it is a dual-functional enzyme. This enzyme is an endonuclease. When the alginate polysaccharide substrate is completely degraded, the final main products are unsaturated disaccharides and unsaturated trisaccharides; when degrading different oligosaccharide substrates, it can also produce saturated M and G or unsaturated Δ and other monosaccharide products. In addition, rAly2 has stable biochemical properties, so it is a potential tool enzyme, which can be used in the fields of medicine and food, and has broad application prospects.
Owner:SHANDONG UNIV

Sea cucumber viscera and ovum suspension method, sea cucumber viscera and ovum suspension liquid and application

The invention relates to the technical field of food processing, in particular to a sea cucumber viscera and ovum suspension method, a sea cucumber viscera and ovum suspension liquid and application. The invention provides the suspension liquid, which is prepared from polyguluronic acid, auxiliary suspension ingredients and solvent water, wherein the mass volume ratio of the polyguluronic acid is 20% to 25%. The suspension liquid provided by the invention can realize the stable suspension on marine organism food; and the appearance is attractive. Particularly for the marine food using sea cucumber viscera and ova as food materials, after the sea cucumber viscera and ova are suspended, the storage time can be prolonged; and the color and luster are maintained unchanged. The sea cucumber viscera and ovum suspension method provided by the invention has the advantages that the process is simple; and the loss of the nutrition ingredients of the sea cucumber viscera and ova is small. The finally obtained sea cucumber viscera and ovum food does not contain preservatives, sugar or salt, and is safer.
Owner:渤海水产育苗(山东)有限公司 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products